Get started
Author

William E. Osai

Observed names: W. Osai, William Osai
OpenAlex ID: A5061251679
Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study
2010 · Lance C. Pagliaro, Dallas L. Williams, et al. · Journal of Clinical Oncology · 400
PDF
Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma
2008 · William E. Osai, Chaan S. Ng, et al. · Anti-Cancer Drugs · 21
Epidermal growth factor receptor expression in and targeted therapy for metastatic squamous cell carcinoma of the penis
2007 · L. C. Pagliaro, W. Osai, et al. · Journal of Clinical Oncology · 5
Abstract 4367: The MD Anderson Symptom Inventory (MDASI) survey discloses persistent moderate to high-level symptoms in cancer survivors
2023 · Katherine Gilmore, Patricia Chapman, et al. · Cancer Research
Integration of patient-reported outcomes into survivorship care.
2022 · Katherine Ramsey Gilmore, Patricia Hansberry Chapman, et al. · Journal of Clinical Oncology
Prostate Cancer Survivorship Care
2018 · Jeri Kim, Spyridon Basourakos, et al. · Springer Publishing Company eBooks
Association between abdominal adiposity, muscle mass, and metabolic syndrome in survivors of testicular germ cell cancer.
2016 · Kyaw Zin Thein, William Osai, et al. · Journal of Clinical Oncology
Genitourinary Cancer Survivorship Management
2014 · Marcia L. Patterson, John W. Davis, et al. · Springer eBooks
Malignant Small Round Blue Cell Tumor of the Kidney Without EWSR1 Rearrangement: Report of a Case and Review of the Literature
2011 · William E. Osai, Elizabeth G. Demicco, et al. · Clinical Genitourinary Cancer
Works count: 9
Citation count: 426
H-index: 3
I10-index: 2
Year
Topic
Type